LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

A gene on a quest: the adventures of Jen

16/03/2025

INFOSHEET

 

Jen is a gene embarking on an expedition to illustrate the full benefits of genetic technologies for people and the planet. Like all other genes, Jen is a segment of DNA carrying genetic information. Scientists have been studying Jen and its potential for a long time. 

 

 

 

 

You can read the full story below and/or download it clicking on the button.

 

Improving lives

During the first stop of their journey, Jen presents the enormous potential of gene therapies. They are one of the most innovative biotech discoveries, that can improve the quality of patients’ lives, by moving from disease management to disease treatment. Indeed, gene therapies can cure, treat, and prevent diseases caused by missing or defective genes by adding or replacing those genes with functional ones.

Finding solutions for patients

In their second stop, Jen illustrates how latest biotech advancements allow scientists to use genes and parts of genes to create vaccines to activate human immune systems and fight infections. Genes can be also inserted into microorganisms to biomanufacture active pharmaceutical ingredients used to produce many other medicines.

Finding cures for diseases

In the third stop, Jen presents an example of genome editing: CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats). CRISPRs allow scientists to make specific, targeted changes in genes. Genome editing is, indeed, considered the easiest, fastest, and most economical way to edit genes and cure genetic diseases. These technologies have opened the door to innovative pathways in healthcare including personalised medicines reducing side-effects in patients.

Preserving the environment

In the final stop of the quest, Jen explains how they are not only fundamental in the healthcare sector but also in many other sectors. Genes can, indeed, be inserted into microorganisms to turn them into factories to produce many kinds of products. One example is enzymes: they can preserve the environment by decomposing toxic substances, cleaning up industrial sites, producing biodegradable plastics, and more.

As this journey comes to an end, Jen is already planning a new adventure. The combination of gene therapies with other biotechnologies but also AI advancements will pave the way to transformative biotech solutions. The future of biotech is now!

A Gene on a Quest: The Adventures of Jen


Download
Share
Communications Team
Communications Team

Related posts

30/09/2025

Public Consultation Response to the European Commission’s 28th Regime proposal


Read more
14/07/2025

EuropaBio Annual Report 2025


Read more
11/07/2025

Industrial Decarbonisation Accelerator Act – EuropaBio Position


Read more

Important links

  • Public Consultation Response to the European Commission’s 28th Regime proposal
  • EuropaBio Annual Report 2025

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.